Abstract
Astrocytes comprise the major cell type in the central nervous system (CNS) and they are essential for support of neuronal functions by providing nutrients and regulating cell-to-cell communication. Astrocytes also are immune-like cells that become reactive in response to neuronal injury. Phospholipases A2 (PLA 2) are a family of ubiquitous enzymes that degrade membrane phospholipids and produce lipid mediators for regulating cellular functions. Three major classes of PLA 2 are expressed in astrocytes: group IV calcium-dependent cytosolic PLA 2 (cPLA2), group VI calcium-independent PLA 2 (iPLA2), and group II secretory PLA 2 (sPLA2). Upregulation of PLA 2 in reactive astrocytes has been shown to occur in a number of neurodegenerative diseases, including stroke and Alzheimer’s disease. This review focuses on describing the effects of oxidative stress, inflammation, and activation of G protein-coupled receptors on PLA 2 activation, arachidonic acid (AA) release, and production of prostanoids in astrocytes.
Similar content being viewed by others
References
Ransom B., Behar T., and Nedergaard M. (2003) New roles for astrocytes (stars at last). Trends Neurosci. 26, 520–522.
Bodin P. and Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem. Res. 26, 959–969.
Neary J.T., Kang Y., Bu Y., et al. (1999) Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J. Neurosci. 19, 4211–4220.
Leslie C.C. (1997) Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272, 16,709–16,712.
Murakami M., Nakatani Y., Atsumi G., et al. (1997) Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17, 225–283.
Six D.A. and Dennis E.A. (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta. 1488, 1–19.
Gijon M.A., Spencer D.M., and Leslie C.C. (2000) Recent advances in the regulation of cytosolic phospholipase A(2). Adv. Enzyme Regul. 40, 255–268.
Murakami M. and Kudo I. (2004) Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog. Lipid Res. 43, 3–35.
Molloy G.Y., Rattray M., and Williams R.J. (1998) Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci. Lett. 258, 139–142.
Sun G.Y. and MacQuarrie R.A. (1989) Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. NY Acad. Sci. 559, 37–55.
Phillis J.W. and O’Regan M.H. (2004) A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res. Brain Res. Rev. 44, 13–47.
Farooqui A.A., Yang H.C., Rosenberger T.A., et al. (1997) Phospholipase A2 and its role in brain tissue. J. Neurochem. 69, 889–901.
Balboa M.A., Varela-Nieto I., Killermann Lucas K., et al. (2002) Expression and function of phospholipase A(2) in brain. FEBS Lett. 531, 12–17.
Sun G.Y., Xu J., Jensen M.D., et al. (2004) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45, 205–213.
Leslie C.C. (2004) Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2. Prostaglandins Leukot. Essent. Fatty Acids 70, 373–376.
De S., Trigueros M.A., Kalyvas A., et al. (2003) Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol. Cell. Neurosci. 24, 753–765.
Kalyvas A. and David S. (2004) Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41, 323–335.
Lauritzen I., Heurteaux C., and Lazdunski M. (1994) Expression of group II phospholipase A2 in rat brain after severe forebrain ischemia and in endotoxic shock. Brain Res. 651, 353–356.
Yagami T., Ueda K., Asakura K., et al. (2002) Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. Mol. Pharmacol. 61, 114–126.
Lin T.N., Simonyi A., Wang Q., et al. (2004) Induction of secretory phospholipase A2 in astrocytes in response to focal cerebral ischemia in the rat brain. J. Neurochem.
Stephenson D., Rash K., Smalstig B., et al. (1999) Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 27, 110–128.
Lu X.R., Ong W.Y., Halliwell B., et al. (2001) Differential effects of calcium-dependent and calcium-independent phospholipase A(2) inhibitors on kainate-induced neuronal injury in rat hippocampal slices. Free Radical Biol. Med. 30, 1263–1273.
Ong W.Y., Lu X.R., Ong B.K., et al. (2003) Quinacrine abolishes increases in cytoplasmic phospholipase A2 mRNA levels in the rat hippocampus after kainate-induced neuronal injury. Exp. Brain Res. 148, 521–524.
Rosenberger T.A., Villacreses N.E., Hovda J.T., et al. (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88, 1168–1178.
Hurt-Camejo E., Camejo G., Peilot H., et al. (2001) Phospholipase A(2) in vascular disease. Circ. Res. 89, 298–304.
Oka S. and Arita H. (1991) Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem. 266, 9956–9960.
Tong W., Hu Z.Y., and Sun G.Y. (1995) Stimulation of group II phospholipase A2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF alpha, and IL-1 beta. Interactive effects. Mol. Chem. Neuropathol. 25, 1–17.
Li W., Xia J., and Sun G.Y. (1999) Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate. J. Interferon Cytokine Res. 19, 121–127.
Xu J., Yu S., Sun A.Y., et al. (2003) Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2). Free Radical Biol. Med. 34, 1531–1543.
Diehl J.A., Tong W., Sun G., et al. (1995) Tumor necrosis factor-alpha-dependent activation of a RelA homodimer in astrocytes. Increased phosphorylation of RelA and MAD-3 precede activation of RelA. J. Biol. Chem. 270, 2703–2707.
Tong W., Shah D., Xu J., et al. (1999) Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in immortalized astrocytes (DITNC). J. Mol. Neurosci. 12, 89–99.
Wang J.H. and Sun G.Y. (2000) Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). Neurochem. Res. 25, 613–619.
Wang J.H. and Sun G.Y. (2001) Ethanol inhibits cytokine-induced iNOS and sPLA2 in immortalized astrocytes: evidence for posttranscriptional site of ethanol action. J. Biomed. Sci. 8, 126–133.
Thomas G., Bertrand F., and Saunier B. (2000) The differential regulation of group II(A) and group V low molecular weight phospholipases A(2) in cultured rat astrocytes. J. Biol. Chem. 275, 10,876–10,886.
Zanassi P., Paolillo M., and Schinelli S. (1998) Coexpression of phospholipase A2 isoforms in rat striatal astrocytes. Neurosci. Lett. 247, 83–86.
Adibhatla R.M., Hatcher J.F., and Dempsey R.J. (2003) Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid. Redox Signal. 5, 647–654.
Owada Y., Tominaga T., Yoshimoto T., et al. (1994) Molecular cloning of rat cDNA for cytosolic phospholipase A2 and the increased gene expression in the dentate gyrus following transient forebrain ischemia [Molecular Brain Research 25 (1994) 364–368]. Brain Res. Mol. Brain Res. 27, 355.
Kishimoto K., Matsumura K., Kataoka Y., et al. (1999) Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain. Neuroscience 92, 1061–1077.
Murakami M., Kambe T., Shimbara S., et al. (1999) Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J. Biol. Chem. 274, 29,927–29,936.
Enomoto A., Murakami M., and Kudo I. (2000) Internalization and degradation of type IIA phospholipase A(2) in mast cells. Biochem. Biophys. Res. Commun. 276, 667–672.
Balboa M.A., Shirai Y., Gaietta G., et al. (2003) Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells. J. Biol. Chem. 278, 48,059–48,065.
Kolko M., de Turco E.B., Diemer N.H., et al. (2002) Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors. Neuroreport 13, 1963–1966.
Rodriguez De Turco E.B., Jackson F.R., DeCoster M.A., et al. (2002) Glutamate signalling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes. J. Neurosci. Res. 68, 558–567.
Yagami T., Ueda K., Asakura K., et al. (2003) Human group IIA secretory phospholipase A2 potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels in cultured rat cortical neurons. J. Neurochem. 85, 749–758.
Copic A., Vucemilo N., Gubensek F., et al. (1999) Identification and purification of a novel receptor for secretory phospholipase A(2) in porcine cerebral cortex. J. Biol. Chem. 274, 26,315–26,320.
Hanasaki K. and Arita H. (2002) Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat. 68–69, 71–82.
Hernandez M., Barrero M.J., Alvarez J., et al. (1999) Secretory phospholipase A2 induces phospholipase Cgamma-1 activation and Ca2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity. Biochem. Biophys. Res. Commun. 260, 99–104.
Hernandez M., Burillo S.L., Crespo M.S., et al. (1998) Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273, 606–612.
Qiu Z.H., Gijon M.A., de Carvalho M.S., et al. (1998) The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophages. J. Biol. Chem. 273, 8203–8211.
Gijon M.A., Spencer D.M., Kaiser A.L., et al. (1999) Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2. J. Cell Biol. 145, 1219–1232.
Fatima S., Khandekar Z., Parmentier J.H., et al. (2001) Cytosolic phospholipase A2 activation by the p38 kinase inhibitor SB203580 in rabbit aortic smooth muscle cells. J. Pharmacol. Exp. Ther. 298, 331–338.
Xue D., Xu J., McGuire S.O., et al. (1999) Studies on the cytosolic phospholipase A2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187. Neurochem. Res. 24, 1285–1291.
Weisman G.A., Turner J.T., and Fedan J.S. (1996) Structure and function of P2 purinocepters. J. Pharmacol. Exp. Ther. 277, 1–9.
Centemeri C., Bolego C., Abbracchio M.P., et al. (1997) Characterization of the Ca2+ responses evoked by ATP and other nucleotides in mammalian brain astrocytes. Br. J. Pharmacol. 121, 1700–1706.
Pearce B., Murphy S., Jeremy J., et al. (1989) ATP-evoked Ca2+ mobilisation and prostanoid release from astrocytes: P2-purinergic receptors linked to phosphoinositide hydrolysis. J. Neurochem. 52, 971–977.
Bruner G. and Murphy S. (1990) ATP-evoked arachidonic acid mobilization in astrocytes is via a P2Y-purinergic receptor. J. Neurochem. 55, 1569–1575.
Seregi A., Doll S., Schobert A., et al. (1992) Functionally diverse purinergic P2Y-receptors mediate prostanoid synthesis in cultured rat astrocytes: the role of ATP-induced phosphatidyl-insoitol breakdown. Eicosanoids 5(Suppl.), S19-S22.
Stella N., Estelles A., Siciliano J., et al. (1997) Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. J. Neurosci. 17, 2939–2946.
Chen W.C. and Chen C.C. (1998) ATP-induced arachidonic acid release in cultured astrocytes is mediated by Gi protein coupled P2Y1 and P2Y2 receptors. Glia 22, 360–370.
Ishimoto H., Nakahata N., Matsuoka I., et al. (1997) Effects of ATP on phosphoinositide hydrolysis and prostaglandin E2 generation in rabbit astrocytes. J. Pharm. Pharmacol. 49, 520–524.
King B.F., Neary J.T., Zhu Q., et al. (1996) P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies. Neuroscience 74, 1187–1196.
Neary J.T., McCarthy M., Kang Y., et al. (1998) Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures. Neurosci. Lett. 242, 159–162.
Weisman G.A., Garrad R.C., Erb L.J., et al. (1999) P2Y receptors in the nervous system: molecular studies of a P2Y2 receptor subtype from NG108-15 neuroblastoma x glioma hybrid cells. Prog. Brain Res. 120, 33–43.
Erb L., Liu J., Ockerhausen J., et al. (2001) An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction. J. Cell. Biol. 153, 491–501.
Bolego C., Ceruti S., Brambilla R., et al. (1997) Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis. Br. J. Pharmacol. 121, 1692–1699.
Xu J., Weng Y.I., Simonyi A., et al. (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J. Neurochem. 83, 259–270.
Evans J.H., Fergus D.J., and Leslie C.C. (2002) Inhibition of the MEK1/ERK pathway reduces arachidonic acid release independently of cPLA2 phosphorylation and translocation. BMC Biochem. 3, 30.
Kennedy B.P., Payette P., Mudgett J., et al. (1995) A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270, 22,378–22,385.
Gendron F.P., Benrezzak O., Krugh B.W., et al. (2002) Purine signaling and potential new therapeutic approach: possible outcomes of NTP-Dase inhibition. Curr. Drug Targets 3, 229–245.
Strokin M., Sergeeva M., and Reiser G. (2003) Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br. J. Pharmacol. 139, 1014–1022.
Tence M., Cordier J., Glowinski J., et al. (1992) Endothelin-evoked release of arachidonic acid from mouse astrocytes in primary culture. Eur. J. Neurosci. 4, 993–999.
Ito Y., Nakashima S., and Nozawa Y. (1997) Hydrogen peroxide-induced phospholipase D activation in rat pheochromocytoma PC12 cells: possible involvement of Ca2+-dependent protein tyrosine kinase. J. Neurochem. 69, 729–736.
Oh S.O., Hong J.H., Kim Y.R., et al. (2000) Regulation of phospholipase D2 by H(2)O(2) in PC12 cells. J. Neurochem. 75, 2445–2454.
Servitja J.M., Masgrau R., Pardo R., et al. (2000) Effects of oxidative stress on phospholipid signaling in rat cultured astrocytes and brain slices. J. Neurochem. 75, 788–794.
Banno Y., Wang S., Ito Y., et al. (2001) Involvement of ERK and p38 MAP kinase in oxidative stress-induced phospholipase D activation in PC12 cells. Neuroreport 12, 2271–2275.
Tournier C., Thomas G., Pierre J., et al. (1997) Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase). Eur. J. Biochem. 244, 587–595.
Samanta S., Perkinton M.S., Morgan M., et al. (1998) Hydrogen peroxide enhances signal-responsive arachidonic acid release from neurons: role of mitogen-activated protein kinase. J. Neurochem. 70, 2082–2090.
Martinez J. and Moreno J.J. (2001) Role of Ca2+-independent phospholipase A2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 392, 257–262.
Konishi H., Tanaka M., Takemura Y., et al. (1997) Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. USA 94, 11,233–11,237.
Vane J.R. (2000) The mechanism of action of anti-inflammatory drugs. Ernst Schering Res. Found. Workshop 1–23.
Hirst W.D., Young K.A., Newton R., et al. (1999) Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. 13, 57–68.
Kyrkanides S., Moore A.H., Olschowka J.A., et al. (2002) Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain. Res. Mol. Brain Res. 104, 159–169.
O’Banion M.K., Miller J.C., Chang J.W., et al. (1996) Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66, 2532–2540.
Dayton E.T. and Major E.O. (1996) Recombinant human interleukin 1 beta induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures. J. Neuroimmunol. 71, 11–18.
Pistritto G., Mancuso C., Tringali G., et al. (1998) The relative contribution of constitutive and inducible cyclooxygenase activity to lipopolysaccharide-induced prostaglandin production by primary cultures of rat hypothalamic astrocytes. Neurosci. Lett. 246, 45–48.
Molina-Holgado E., Ortiz S., Molina-Holgado F., et al. (2000) Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol. 131, 152–159.
Brambilla R. and Abbracchio M.P. (2001) Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann. NY Acad. Sci. 939, 54–62.
Xu J., Chalimoniuk M., Shu Y., et al. (2003) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot. Essent. Fatty Acids 69, 437–448.
Toyomoto M., Ohta M., Okumura K., et al. (2004) Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett. 562, 211–215.
Lee R.K., Knapp S., and Wurtman R.J. (1999) Prostaglandin E2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants. J. Neurosci. 19, 940–947.
Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., Levison S.W. (2004) Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89, 1092–1100.
Boilard E., Bourgoin S.G., Bernatchez C., et al. (2003) Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2. Blood 102, 2901–2909.
Nakatani Y., Tanioka T., Sunaga S., et al. (2000) Identification of a cellular protein that functionally interacts with the C2 domain of cytosolic phospholipase A(2)alpha. J. Biol. Chem. 275, 1161–1168.
Gaudreault S.B., Chabot C., Gratton J.P., et al. (2004) The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity. J. Biol. Chem. 279, 356–362.
Kenworthy A. (2002) Peering inside lipid rafts and caveolae. Trends Biochem. Sci. 27, 435–437.
Yang H.C., Mosior M., Johnson C.A., et al. (1999) Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal. Biochem. 269, 278–288.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, G.Y., Xu, J., Jensen, M.D. et al. Phospholipase A2 in astrocytes. Mol Neurobiol 31, 27–41 (2005). https://doi.org/10.1385/MN:31:1-3:027
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MN:31:1-3:027